Browse By Person: Adams, Mark
|Up a level|
Group by: Item Type | Date
Number of items: 6.
Ramsay, Andrew J., Reid, Janet C., Adams, Mark N., Samaratunga, Hemamali, Dong, Ying, Clements, Judith A., et al. (2008) Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biological Chemistry, 389(6), pp. 653-668.
He, Yaowu, Wortmann, Andreas, Burke, Leslie, Reid, Janet, Adams, Mark, Abdul-Jabbar, Ibtissam, et al. (2010) Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKC? Journal of Biological Chemistry, 285(34), pp. 26162-26173.
Adams, Mark, Ramachandran, Rithwik, Yau, Mei-Kwan, Suen, Jacky, Fairlie, David, Hollenberg, Morley, et al. (2011) Structure, function and pathophysiology of protease activated receptors. Pharmacology and Therapeutics, 130(3), pp. 248-282.
Adams, Mark, Christensen, Melinda, He, Yaowu, Waterhouse, Nigel, & Hooper, John (2011) The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS ONE, 6(11), pp. 1-14.
Adams, Mark N. (2012) In vitro and in vivo studies on protease-activated receptor-2. PhD thesis, Queensland University of Technology.
Jekimovs, Christian, Bolderson, Emma, Suraweera, Amila, Adams, Mark, O'Byrne, Kenneth J., & Richard, Derek J. (2014) Chemotherapeutic compounds targeting the DNA double-strand break repair pathways : the good, the bad, and the promising. Frontiers in Oncology, 4(86).